Global Health (Medanta) vs Nifty 50: Returns Compared

Global Health (Medanta) vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Global Health (Medanta) trades on the NSE under the symbol MEDANTA, and its 1M return of +5.11% compares with the Nifty 50's -1.44% over the same period.

The Global Health (Medanta) vs Nifty 50 comparison matters because Global Health (Medanta) is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Global Health (Medanta) share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, using NSE closing data.

Click Here – Get Free Investment Predictions

Global Health (Medanta) vs Nifty 50: Performance at a Glance

The table below sets out Global Health (Medanta) vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 31 August 2026.

Time Frame	Global Health (Medanta) Return	Nifty 50 Return	Difference
1 Month	+5.11%	-1.44%	+6.55% pp
3 Months	+26.4%	+2.78%	+23.63% pp
6 Months	+30.74%	-3.35%	+34.1% pp
1 Year	+5.83%	-2.41%	+8.24% pp
3 Years	+108.25% (Global Health (Medanta))	+23.65% (Nifty 50)	+84.6% pp

On the Global Health (Medanta) vs Nifty 50 scorecard, Global Health (Medanta) has stayed ahead of the index over the most recent one-year window. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter's swing.

Check the Univest Screener for live Global Health (Medanta) and Nifty 50 data

Why the Global Health (Medanta) vs Nifty 50 Gap Exists

Global Health (Medanta)'s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Global Health (Medanta) vs Nifty 50 return table above.

A second factor behind the Global Health (Medanta) vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Global Health (Medanta)'s price sharply in either direction over short periods, while the Nifty 50's return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock's swings.

Download the Univest iOS App or Univest Android App to track Global Health (Medanta) and Nifty 50 live on the go.

Global Health (Medanta) vs Nifty 50: Has Global Health (Medanta) Beaten the Benchmark?

Global Health (Medanta) has beaten the Nifty 50 over the past year, gaining +5.83% against the index's -2.41% over the same period. Over the longer term the picture has stayed in the stock's favour.

Risks of the Global Health (Medanta) vs Nifty 50 Comparison

Reading too much into a Global Health (Medanta) vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Global Health (Medanta) carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50's more liquid, blended profile. A stock's 52-week range of Rs 956.00 to Rs 1,544.00 also shows the kind of volatility that a single-stock investment carries relative to a broad index.

Conclusion

Global Health (Medanta) vs Nifty 50 highlights how a single stock's return path can differ from a diversified benchmark over different time horizons. Investors weighing the Global Health (Medanta) vs Nifty 50 record should factor in Global Health (Medanta)'s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.

Has Global Health (Medanta) outperformed the Nifty 50 in the last year?

Ans. Yes. Global Health (Medanta) gained +5.83% over the past year while the Nifty 50 returned -2.41% over the same period, based on NSE closing prices to 31 August 2026.

How does Global Health (Medanta) vs Nifty 50 look over 3 years?

Ans. Over three years Global Health (Medanta) has returned +108.25% compared with the Nifty 50's +23.65%, so in the Global Health (Medanta) vs Nifty 50 comparison the stock has been ahead over this horizon.

What is the Global Health (Medanta) share price today compared to Nifty 50?

Ans. Global Health (Medanta) share price stood at Rs 1,477.40 on NSE, while the Nifty 50 traded at 24,031.60 based on the same closing data window.

What is the 52-week high and low of Global Health (Medanta)?

Ans. Global Health (Medanta)'s 52-week high is Rs 1,544.00 and its 52-week low is Rs 956.00, based on NSE data.

Why does Global Health (Medanta) show bigger price swings than the Nifty 50?

Ans. Global Health (Medanta) carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Global Health (Medanta)'s price more sharply than the diversified index, a key reason the Global Health (Medanta) vs Nifty 50 return gap varies across time frames.

Is Global Health (Medanta) a good long-term investment compared to a Nifty 50 index fund?

Ans. Global Health (Medanta)'s suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Global Health (Medanta) vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.